AI drug discovery company

Polyphron

Data as of Oct 17, 2026.

Company facts

Founded

2024

ReportedSource for founded (opens in new tab)
Headquarters

United States (New York, NY)

ConfirmedSource for headquarters (opens in new tab)

Latest funding round

Round: Seed
Date: Sep 2026
Amount: $20M
Lead investor: Quiet Capital

ReportedSource for the latest round (opens in new tab)

Recent news

Sep 28, 2026

REPROCELL collaboration to supply donor-diverse iPSCs for its human tissue platform

ConfirmedSource (opens in new tab)
Sep 17, 2026

$20M seed for AI-verified human tissue foundry, NYC

ReportedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.